ARTICLE | Company News
Transgene, Association Francaise Contre Les Myopathies deal
December 7, 1998 8:00 AM UTC
The partners renewed until June 30, 2001 their agreement to develop gene therapy treatments for neuromuscular diseases, with a focus on Duchenne's Muscular Dystrophy (DMD). AFM will provide $14.7 mill...